Company Filing History:
Years Active: 2021
Title: Frank Blocki: Innovator in Renal Function Prognostics
Introduction
Frank Blocki is an accomplished inventor based in Hayfield, Minnesota, known for his significant contributions to the field of medical diagnostics. He holds a patent that focuses on the use of 1,25-dihydroxyvitamin D values in conjunction with parathyroid hormone (PTH) levels as a prognostic biomarker for renal function.
Latest Patents
Frank Blocki's patent, titled "Use of 1,25-dihydroxyvitamin D values in ratio with PTH as a prognostic biomarker," presents a novel method for predicting or stratifying the risk of worsening renal function in patients at risk of renal injury. This invention utilizes the measurement of 1,25-dihydroxyvitamin D levels in biological samples, combined with PTH levels, to provide a ratio that indicates the risk of worsening renal function.
Career Highlights
Throughout his career, Frank Blocki has demonstrated a commitment to advancing medical science and improving patient outcomes. His innovative approach to renal function assessment has the potential to significantly impact clinical practices and patient care.
Collaborations
Frank has collaborated with notable colleagues in his field, including Francesco Colotta and Fabrizio Bonelli, contributing to the development and refinement of his groundbreaking work.
Conclusion
Frank Blocki's contributions to the field of renal function prognostics exemplify the importance of innovation in medical diagnostics. His patent represents a significant advancement in predicting renal injury, showcasing his dedication to improving healthcare outcomes.